Transplant Medicine
Findings describe new data in transplant medicine research
Published in Hepatitis Weekly, September 12th, 2005
Study 1: Combination therapy treats hepatitis C reinfection after liver transplantation.
According to a study from Germany, "recurrence of hepatitis C virus (HCV) infection after orthotopic liver transplantation (OLT) is a virtually universal occurrence, and a significant proportion of patients develop chronic hepatitis and cirrhosis. The aim of this study was to evaluate the safety and efficacy of interferon (IFN)-alpha 2b plus ribavirin (RIBA) in the treatment of recurrent HCV after OLT over the long term."
"Fifteen patients with recurrent HCV infection...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-09-12)
More Articles from Hepatitis Weekly
- Hemophilia Complications
Researchers analyze HCV and HIV in co-infected hemophiliacs - Hepatitis B Virus
Minipool nucleic acid testing effective against transfusion-transmitted HBV - Hepatitis B Virus
Novel immunostimulator proves a good weapon in fight against HBV - Hepatitis C Virus
Scientists develop viral culture system to help define antiviral strategies - Hepatitis C Virus Treatment
Caution required with systemic corticosteroids due to adverse effects on HCV - Acute Lymphoblastic Leukemia
Pediatric protocols yield better outcomes for young-adult ALL patients - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
